| Announce Date | 08/13/2024 |
| EPS Normalized Actual | $0.2152 (Beat by $0.1352) |
| EPS GAAP Actual | $0.2152 (Beat by $0.1352) |
| Revenue Actual | $0.108009B |
| Revenue Surprise | Beat by $108.009M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.08 |
| EPS GAAP Estimate | $0.08 |
| Revenue Estimate | $0.0849B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 0.26 | 26.12 | 0.26 | 0.26 | 1 |
| Dec 2030 | 0.26 | 26.12 | 0.26 | 0.26 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.11 | -0.18 | 0.108009B | 14.76% | 29.91M |
| FQ2 2025 (Jun 2025) | -0.36 | 0.16 | 0.113104B | 5.35% | 41M |
| FQ1 2025 (Mar 2025) | 0.06 | -0.05 | 0.099226B | -11.07% | -4.07M |
| FQ4 2024 (Dec 2024) | 0.16 | -1.38141 | 0.100936B | -7.11% | -12.97M |
| FQ3 2024 (Sep 2024) | -0.098 | -1.44059 | 0.092072B | -11.02% | -19.97M |
| FQ2 2024 (Jun 2024) | 0.22 | 0.22 | 0.107053B | -0.15% | 107.05M |
| FQ1 2024 (Mar 2024) | -0.14 | -0.14 | 0.110215B | 7.11% | 110.22M |
| FQ4 2023 (Dec 2023) | -2.12 | -2.12 | 0.108108B | -168.75% | 108.11M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.08
Consensus Revenue Estimates
0.0849B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 0.06 | -- | 0.06 | 0.06 | 1 |
| FQ2 2027 (Jun 2027) | 0.06 | -- | 0.06 | 0.06 | 1 |
| FQ1 2027 (Mar 2027) | 0.06 | -- | 0.06 | 0.06 | 1 |
| FQ4 2026 (Dec 2026) | 0.03 | -- | 0.03 | 0.03 | 1 |
| FQ3 2026 (Sep 2026) | 0.03 | 466.67 | 0.03 | 0.03 | 1 |
| FQ2 2026 (Jun 2026) | 0.1 | 460 | 0.1 | 0.1 | 1 |
| FQ1 2026 (Mar 2026) | 0.08 | 25 | 0.08 | 0.08 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 0.09B | -- | 0.09B | 0.09B | 6 |
| FQ2 2027 (Jun 2027) | 0.09B | -- | 0.09B | 0.09B | 6 |
| FQ1 2027 (Mar 2027) | 0.09B | -- | 0.09B | 0.09B | 6 |
| FQ4 2026 (Dec 2026) | 0.09B | -- | 0.09B | 0.09B | 10 |
| FQ3 2026 (Sep 2026) | 0.09B | -25.88 | 0.09B | 0.09B | 10 |
| FQ2 2026 (Jun 2026) | 0.09B | -30.76 | 0.09B | 0.09B | 10 |
| FQ1 2026 (Mar 2026) | 0.08B | -16.87 | 0.08B | 0.08B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.07 | -0.11 | -0.18 | 163.64% |
| FQ2 2025 (Jun 2025) | -0.52 | -0.36 | 0.16 | -44.44% |
| FQ1 2025 (Mar 2025) | 0.11 | 0.06 | -0.05 | -83.33% |
| FQ4 2024 (Dec 2024) | 1.54141 | 0.16 | -1.38141 | -863.38% |
| FQ3 2024 (Sep 2024) | 1.34259 | -0.098 | -1.44059 | 1469.99% |
| FQ2 2024 (Jun 2024) | 0.22 | 0.22 | 100% | |
| FQ1 2024 (Mar 2024) | -0.14 | -0.14 | 100% | |
| FQ4 2023 (Dec 2023) | -2.12 | -2.12 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.08B | $0.11B | $29.91M | 27.69% |
| FQ2 2025 (Jun 2025) | $0.07B | $0.11B | $41M | 36.25% |
| FQ1 2025 (Mar 2025) | $0.1B | $0.1B | $-4.07M | -4.11% |
| FQ4 2024 (Dec 2024) | $0.11B | $0.1B | $-12.97M | -12.85% |
| FQ3 2024 (Sep 2024) | $0.11B | $0.09B | $-19.97M | -21.69% |
| FQ2 2024 (Jun 2024) | $0B | $0.11B | $107.05M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.11B | $110.22M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.11B | $108.11M | 100% |